Market Research Report

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Report By Treatment (Medication, Stem Cell Transplant, And Blood Transfusion) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11210464
April 2021
Report Formats: Electronic (PDF), MS EXCEL
As per this study, the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a chronic hematological disorder, i.e. disorder which primarily affects the blood. It is an ultra-rare disease of bone marrow stem cells which affects more than 20,000 people globally. This disease affects men and women equally. Physical symptoms can begin at any age, they usually develop between 30-40 years of age. The only curative therapy for PNH patients is allogeneic stem cell transplantation.
 
Market Dynamics
 
The rise in a number of blood and bone marrow related disorders and increase in geriatric population are the key factors which drive the market growth of PNH treatment market. In addition to this, the emergence of biologics and adoption of novel therapeutics are further pushing the market growth. However, adverse effects associated with currently available treatments, increase in the cost of medical equipment, specifically surgical equipment required for stem cell transformation are some factors that restrain market growth of PNH.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of paroxysmal nocturnal hemoglobinuria (PNH) treatment.
 
Market Segmentation
 
The broad paroxysmal nocturnal hemoglobinuria (PNH) treatment market has been sub-grouped into treatment. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment
  • Medication
  • Stem Cell Transplant
  • Blood Transfusion
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for paroxysmal nocturnal hemoglobinuria (PNH) treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Share by Region (Representative Graph)
 
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the paroxysmal nocturnal hemoglobinuria (PNH) treatment market include Alexion Pharmaceuticals, Inc., Akari Therapeutics, Apellis, Achillion, Others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Treatment
           3.7.2 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Historical and Forecast Data
       6.3 Analysis by Treatment
       6.4 Medication Historic and Forecast Sales by Regions
       6.5 Stem Cell Transplant Historic and Forecast Sales by Regions
       6.6 Blood Transfusion Historic and Forecast Sales by Regions
 
7 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America Sales Analysis
           7.3.1. Overview, Historic and Forecast Sales Analysis
           7.3.2. North America By Segment Sales Analysis
           7.3.3. North America By Country Sales Analysis
           7.3.4. United State Sales Analysis
           7.3.5. Canada Sales Analysis
           7.3.6. Mexico Sales Analysis
       7.4. Europe Sales Analysis
           7.4.1. Overview, Historic and Forecast Sales Analysis
           7.4.2. Europe by Segment Sales Analysis
           7.4.3. Europe by Country Sales Analysis
           7.4.4. United Kingdom Sales Analysis
           7.4.5. France Sales Analysis
           7.4.6. Germany Sales Analysis
           7.4.7. Italy Sales Analysis
           7.4.8. Russia Sales Analysis
           7.4.9. Rest Of Europe Sales Analysis
       7.5. Asia Pacific Sales Analysis
           7.5.1. Overview, Historic and Forecast Sales Analysis
           7.5.2. Asia Pacific by Segment Sales Analysis
           7.5.3. Asia Pacific by Country Sales Analysis
           7.5.4. China Sales Analysis
           7.5.5. India Sales Analysis
           7.5.6. Japan Sales Analysis
           7.5.7. South Korea Sales Analysis
           7.5.8. Australia Sales Analysis
           7.5.9. Rest Of Asia Pacific Sales Analysis
       7.6. Latin America Sales Analysis
           7.6.1. Overview, Historic and Forecast Sales Analysis
           7.6.2. Latin America by Segment Sales Analysis
           7.6.3. Latin America by Country Sales Analysis
           7.6.4. Brazil Sales Analysis
           7.6.5. Argentina Sales Analysis
           7.6.6. Peru Sales Analysis
           7.6.7. Chile Sales Analysis
           7.6.8. Rest of Latin America Sales Analysis
       7.7. Middle East & Africa Sales Analysis
           7.7.1. Overview, Historic and Forecast Sales Analysis
           7.7.2. Middle East & Africa by Segment Sales Analysis
           7.7.3. Middle East & Africa by Country Sales Analysis
           7.7.4. Saudi Arabia Sales Analysis
           7.7.5. UAE Sales Analysis
           7.7.6. Israel Sales Analysis
           7.7.7. South Africa Sales Analysis
           7.7.8. Rest Of Middle East And Africa Sales Analysis
 
8 . COMPETITIVE LANDSCAPE OF THE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT COMPANIES
       8.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT INDUSTRY
       9.1. Top 10  Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Alexion Pharmaceuticals Inc.
           9.3.1. Company Overview
           9.3.2. Company Revenue
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Akari Therapeutics
           9.4.1. Company Overview
           9.4.2. Company Revenue
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Apellis.
           9.5.1. Company Overview
           9.5.2. Company Revenue
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Achillion.
           9.6.1. Company Overview
           9.6.2. Company Revenue
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Others
           9.7.1. Company Overview
           9.7.2. Company Revenue
           9.7.3. Products
           9.7.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Treatment (USD MN)
  •  Medication Market Sales by Geography (USD MN)
  •  Stem Cell Transplant Market Sales by Geography (USD MN)
  •  Blood Transfusion Market Sales by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Treatment
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Treatment (USD MN)
  •  Medication Market Sales by Geography (USD MN)
  •  Stem Cell Transplant Market Sales by Geography (USD MN)
  •  Blood Transfusion Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Companies Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials